Provided by Tiger Trade Technology Pte. Ltd.

Pampa Energia SA

79.76
-0.8000-0.99%
Post-market: 80.260.5000+0.63%16:44 EDT
Volume:257.60K
Turnover:20.43M
Market Cap:4.29B
PE:7.59
High:81.24
Open:80.50
Low:78.55
Close:80.56
52wk High:94.50
52wk Low:54.95
Shares:53.74M
Float Shares:25.10M
Volume Ratio:1.57
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):10.51
EPS(LYR):6.93
ROE:15.26%
ROA:4.21%
PB:1.34
PE(LYR):11.51

Loading ...

Argentine Stocks Rise 0.3% In Morning Trading

Dow Jones
·
Jun 08

Argentine Stocks Fall 2.8%

Dow Jones
·
Jun 06

Argentine Stocks Rally 2.4%

Dow Jones
·
Jun 02

Argentine Stocks Add 0.2% In Morning Trading

Dow Jones
·
May 19

Argentine Stocks Decline 1.2% In Morning Trading

Dow Jones
·
May 13

Argentine Stocks Gain 0.7% In Early Trading

Dow Jones
·
May 11

Argentine Stocks Decline 1.4% In Early Trading

Dow Jones
·
May 07

Pampa Energia Q1 EPS $3.90 Beats $1.58 Estimate, Sales $573.000M Miss $629.919B Estimate.

Benzinga Earnings
·
May 07

Pampa Energia SA expected to post earnings of $1.15 a share - Earnings Preview

Reuters
·
May 05

Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 04

Earning Preview: Pampa Energia SA this quarter’s revenue is expected to increase by 22.59%, and institutional views are bullish

Earnings Agent
·
Apr 30

Addex Therapeutics announces GABAB PAM candidate data

TIPRANKS
·
Apr 29

Press Release: Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model

Dow Jones
·
Apr 29

Major Insider Move Shakes Up the Outlook for Pampa Energia SA

TIPRANKS
·
Apr 24

Creightons Rebrands as Potter & Moore with New PAM Ticker

TIPRANKS
·
Apr 23

Press Release: Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026

Dow Jones
·
Apr 23

Major Insider Move at Pampa Energia SA Shakes Up Investor Watchlists

TIPRANKS
·
Apr 22

Press Release: Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model

Dow Jones
·
Apr 21

Optima Health lifts profit outlook and strengthens position with PAM acquisition

TIPRANKS
·
Apr 17

Optima Health Launches £35m Underwritten Open Offer to Fund PAM Deal and Boost Growth

TIPRANKS
·
Mar 31